Asia Pacific Radiopharmaceutical Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Radiopharmaceuticals are a group of pharmaceutical drugs that contains radioactive isotopes. They are also used as therapeutic and diagnostic agents. Radiopharmaceuticals are used for molecular imaging, involving in the use of these molecules as biomarkers for precise molecular processes that control the progress of a disease. The Asian radiopharmaceutical market is expected to grow rapidly due to increasing awareness among individuals and rising diagnostic rates. This will fuel the demand for SPECT and PET devices in this market. Another factor for its growth is the rise in the number of healthcare facilities and improvement in hospitality. Since most of the countries in this region are developing nations, and working towards the establishment of a stable and efficient healthcare system, it will be an excellent opportunity for the sale of radiopharmaceutical products. APAC Radiopharmaceuticals market was valued at USD 2 billion in 2020 and is expected to be valued at USD 5.6 billion by 2030, witnessing an approximate CAGR of 10.9% over the forecast period.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020159
Market Dynamics and Factors:
Radiopharmaceutical diagnostic techniques offer a better insight into the disease than the conventionally used diagnostic devices, including x-ray, CT, ultrasound, and MRI. Since these diagnostic techniques are new to the developing countries, the scope for the growth is more. On the other hand, strict regulation of the radioactive elements, complex manufacturing processes, and comparatively high prices of the devices are the major restraints. High efficiency, ability to mix with other diagnostic techniques such as x-ray and growing awareness of this technique in the developing market are the major factors expected to fuel the growth of the diagnostic radiopharmaceuticals during the forecast period.
Market Segmentation :
Asia Pacific Radiopharmaceutical Market – By Source
Nuclear Reactors
Cyclotrons
Asia Pacific Radiopharmaceutical Market – By Radioisotope
Technetium-99
Gallium-67
Iodine-123
Iodine-125
18F
Rubidium-82
Yttrium-90
Lutetium-177
Others
Asia Pacific Radiopharmaceutical Market – By Application
Gastro-intestinal
Oncology
Brachytherapy
Others
Nephrology
Cardiology
Neurology
Inflammation
Others
Asia Pacific Radiopharmaceutical Market – By Type
PET/CT
SPECT
Therapeutics
Asia Pacific Radiopharmaceutical Market – By End-User
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Cancer Research Institutes
Others
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020159
Geographic Analysis:
Japan, China, India, Australia, and South Korea, holds major shares of the market in the Asia Pacific due to the production of radioisotopes, out of which Japan is the major producer of the same. The market in Japan is expected to be prominent during the forecast period due to the activities of Sumitomo Corporation, which supplies radioactive raw material to radiopharmaceutical companies. After the introduction of a new accelerator system for the production of radioisotopes in Japan and Australia the radiopharmaceutical market is expected to grow at a higher pace. Some of the factors likely to boost the radiopharmaceutical market in the Asia Pacific are increasing in access to healthcare services, growth in per capita income, rise in demand for radiopharmaceuticals, the surge in the incidence of cancer and heart-related diseases, and speedy introduction of advanced technological systems such as PET/CT, SPECT.
Competitive Scenario:
The major players of the operating in the market are GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt, Siemens Healthiness, Advanced Accelerator Applications, Bayer AG, Eckert & Ziegler, IBA Radiopharma Solutions, Philips, and Jubilant Life Sciences Limited.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020159
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Asia Pacific Radiopharmaceutical industry, although key threats, opportunities and disruptive technologies that could shape the Asia Pacific Radiopharmaceutical Market supply and demand.
The report tracks the leading market players that will shape and impact the Asia Pacific Radiopharmaceutical Market most.
The data analysis present in the Asia Pacific Radiopharmaceutical Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Asia Pacific Radiopharmaceutical Market business.
The 2021 Annual Asia Pacific Radiopharmaceutical Market offers:
100+ charts exploring and analysing the Asia Pacific Radiopharmaceutical Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Asia Pacific Radiopharmaceutical Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020159
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/